Find information on uncontrolled diabetes, including clinical documentation tips, medical coding guidelines (ICD-10-CM codes E11.65, E11.40, E11.51, E11.8, E11.9), and healthcare resources for managing uncontrolled type 1 and type 2 diabetes. Learn about complications, treatment options, and best practices for documenting uncontrolled diabetes in medical records to ensure accurate coding and reimbursement. This resource provides essential information for healthcare professionals, coders, and clinicians involved in diabetes care.
Also known as
Diabetes mellitus
Covers various types of uncontrolled diabetes.
Type 1 diabetes
Includes poorly controlled type 1 diabetes.
Type 2 diabetes
Includes poorly controlled type 2 diabetes.
Long term (current) drug therapy
May be used if diabetes meds are not achieving control.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diabetes Type 1?
Yes
With complications?
No
Is the diabetes Type 2?
When to use each related code
| Description |
|---|
| Uncontrolled Diabetes |
| Hyperosmolar Hyperglycemic State |
| Diabetic Ketoacidosis |
Q: What are the most effective strategies for improving glycemic control in patients with uncontrolled type 2 diabetes despite metformin and sulfonylurea therapy?
A: When metformin and sulfonylurea prove insufficient for achieving optimal glycemic control in type 2 diabetes, several evidence-based strategies can be considered. Adding a third oral agent like a DPP-4 inhibitor, SGLT2 inhibitor, or thiazolidinedione is often recommended, depending on patient-specific factors like renal function and cardiovascular risk. Alternatively, initiating basal insulin or a GLP-1 receptor agonist can provide significant A1C reduction. Clinical trials like the ACCORD, ADVANCE, and VADT studies offer valuable insights into the risks and benefits of intensive glycemic control in this population. Patient education and lifestyle interventions, including medical nutrition therapy and increased physical activity, remain crucial for long-term success. Consider implementing a multidisciplinary approach involving certified diabetes educators, registered dietitians, and mental health professionals to address the complex needs of patients with uncontrolled diabetes. Explore how individualized treatment plans can improve patient adherence and outcomes.
Q: How can clinicians effectively address medication non-adherence in patients with uncontrolled diabetes and co-existing depression?
A: Medication non-adherence is a significant challenge in managing uncontrolled diabetes, particularly in patients with co-existing depression. Clinicians should screen for depression using validated tools like the PHQ-9 and consider collaborative care models integrating mental health services into diabetes management. Addressing underlying psychosocial barriers, such as financial hardship, medication side effects, or lack of social support, is critical. Shared decision-making and motivational interviewing techniques can empower patients to actively participate in their care and improve adherence. Simplifying medication regimens, providing clear instructions, and utilizing medication reminder systems can also be helpful. Explore the impact of integrated care models on diabetes outcomes and patient satisfaction. Learn more about evidence-based strategies for addressing medication non-adherence in complex patient populations.
Patient presents with uncontrolled diabetes mellitus, characterized by persistent hyperglycemia despite ongoing diabetes management. Presenting symptoms include polyuria, polydipsia, polyphagia, and unexplained weight loss. The patient reports difficulty managing blood glucose levels, with frequent readings exceeding target ranges. HbA1c is elevated at [Insert Value, e.g., 9.5%], indicating poor glycemic control over the past 2-3 months. Review of systems reveals complaints of fatigue, blurred vision, and occasional numbness and tingling in the extremities, suggestive of diabetic neuropathy. Assessment includes comprehensive metabolic panel, lipid profile, and urine microalbumin to assess for diabetes-related complications such as diabetic nephropathy and dyslipidemia. Current medication regimen includes [List current medications and dosages]. Diagnosis of uncontrolled diabetes is confirmed based on elevated HbA1c, persistent hyperglycemia, and reported symptoms. Plan includes adjustment of current diabetes medication regimen, reinforcement of diabetes self-management education including carbohydrate counting, blood glucose monitoring, and lifestyle modifications focusing on diet and exercise. Referral to a registered dietitian and certified diabetes educator is recommended for comprehensive diabetes management support. Follow-up scheduled in [Timeframe, e.g., 2 weeks] to monitor response to treatment and adjust management plan as needed. Patient education provided regarding the importance of medication adherence, regular blood glucose monitoring, and lifestyle modifications to achieve optimal glycemic control and mitigate the risk of long-term diabetes complications.